Subscribe to Business

The Lead

Teva’s Potential $40 Billion Acquisition of Mylan Could Transform Generics Space

April 24, 2015 11:26 am | by GlobalData | News | Comments

Mylan made an unsolicited $28.9 billion offer to buy the Irish drugmaker last week, but Perrigo’s board of directors unanimously rejected the proposal, saying that the merger substantially undervalues the company and its future growth prospects.

AstraZeneca Profit Falls as Patent Expires on Heartburn Drug

April 24, 2015 10:43 am | by The Associated Press | News | Comments

Anglo-Swedish drug-maker AstraZeneca PLC reported a 7 percent fall in net profit for the first...

Aerie Pharma Plunges Aftermarket as Rhopressa Study Fails

April 24, 2015 10:35 am | by The Associated Press | News | Comments

Shares of Aerie Pharmaceuticals lost two-thirds of their value in after-market trading after the...

Divestment Gains Boost Net Earnings at Novartis

April 23, 2015 4:48 pm | by The Associated Press | News | Comments

Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit...

View Sample

FREE Email Newsletter

Mylan Launches Generic Sofosbuvir Tablets, MyHep, in India

April 23, 2015 10:30 am | by PRNewswire | News | Comments

The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.

Roche Reports Strong Sales Growth in The First Quarter of 2015

April 22, 2015 11:17 am | by Roche | News | Comments

The Roche Group posted strong sales growth in the first three months in both divisions, with demand for oncology and immunology medicines driving growth in pharmaceuticals, and immunodiagnostics products driving growth in diagnostics.

Robotics And Medical Marijuana — A Joint Venture

April 21, 2015 11:03 am | by Meagan Parrish, Editor, Chem.Info | Articles | Comments

A startup company that’s found a unique niche in the exploding cannabis industry, Potbotics uses robotic technology to bring medical marijuana use into a new era of high-tech pharma.


Eli Lilly Biomanufacturing Plant For Sale

April 21, 2015 10:54 am | News | Comments

CBRE Group, Inc. announced today that they have been hired to sell Eli Lilly’s biomanufacturing plant in Vacaville, California.

ELC Group Signs Regulatory Affairs Contract With Chinese Pharma Giant

April 21, 2015 10:43 am | by ELC Group | News | Comments

ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it has been awarded a 1.5 million Euro contract by one of China’s biggest pharmaceutical companies.

Teva Offers to Buy Mylan in $40.1B Cash-And-Stock Deal

April 21, 2015 10:29 am | by The Associated Press | News | Comments

The potential combination would result in a powerhouse of a generic drug developer competing against rivals such as Sun Pharma.

Mylan Comments on Merger Speculation

April 20, 2015 10:36 am | by PRNewswire | News | Comments

Mylan Executive Chairman Robert J. Coury commented, "We note that there has been some media speculation with regard to a potential bid for Mylan by Teva and that this rumor has been circulating for some time."

AGTC and 4D Molecular Therapeutics Sign Collaboration Agreement

April 20, 2015 10:30 am | by Globe Newswire | News | Comments

Applied Genetic Technologies Corporation and 4D Molecular Therapeutics, leaders in next-generation adeno-associated virus gene therapy vector discovery and product development, today announced a collaboration and license agreement to discover and develop optimized AAV vectors to treat specific ophthalmic disease indications with high unmet medical need.


Fed Grant for Pain-Free Blood Test Startup at UW

April 17, 2015 12:32 pm | by University of Wisconsin - Madison | News | Comments

A company with deep roots at the University of Wisconsin-Madison wants to make blood sampling less painful and more convenient.

Sartorius Stedim Biotech Acquires BioOutsource

April 17, 2015 12:10 pm | by Sartorius Stedim Biotech Group | News | Comments

Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.

Physicians Want Dr. Oz Gone From Columbia Medical Faculty

April 17, 2015 10:53 am | by Verena Dobnik, Associated Press | News | Comments

A group of top doctors has demanded Columbia University remove Dr. Oz, citing his "egregious lack of integrity" for promoting what they call "quack treatments."

CollabRx and Medytox Solutions Sign Definitive Merger Agreement

April 16, 2015 3:47 pm | by Globe Newswire | News | Comments

Medytox currently owns and operates several healthcare companies, including clinical testing laboratories, an electronic medical records provider, a laboratory information systems company and a medical billing company. CollabRx is a leading informatics company focused on the interpretation of complex molecular and genetic tests in cancer.

Sagent Pharmaceuticals Appoints Michael Logerfo as President

April 16, 2015 3:39 pm | by Globe Newswire | News | Comments

Sagent Pharmaceuticals, Inc., a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its current EVP and Chief Legal Officer Michael Logerfo has been appointed President.


Medac Pharma Announces Settlement Of Patent Infringement Lawsuits

April 16, 2015 3:17 pm | by PRNewswire | News | Comments

Medac Pharma, Inc., a privately-held pharmaceutical company, today announced that it and its parent company, medac GmbH, have settled all litigation and patent office proceedings with Antares Pharma, Inc. 

OriGen Biomedical Issues Nationwide Recall

April 16, 2015 11:20 am | by OriGen Biomedical | News | Comments

OriGen Biomedical initiated a nationwide recall for one lot of Reinforced Dual Lumen ECMO catheters.

Catalent Announces $52 Million Kentucky Expansion

April 16, 2015 11:01 am | by Catalent Pharma Solutions | News | Comments

Catalent Pharma Solutions announced the opening of a large scale expansion at its Winchester, KY, manufacturing facility.

Innocrin Raises $28 Million in Series D Financing

April 15, 2015 11:10 am | by Innocrin Pharmaceuticals | News | Comments

Innocrin Pharmaceuticals is developing small-molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers.

French Lawmakers OK Healthcare Bill Targeting Anorexia

April 15, 2015 10:53 am | by Sylvie Corbet, Associated Press | News | Comments

Too-thin models, too much drinking, sexy cigarette packs: France's parliament is cracking down on all of these in a sweeping bill designed to improve public health and trim public health costs.

Congress OKs Bill Reshaping Medicare Doctors' Fees

April 15, 2015 10:48 am | by Alan Fram, Associated Press | News | Comments

The Senate gave final approval late Tuesday to the $214 billion bipartisan measure, which permanently recasts how Medicare reimburses doctors for treating over 50 million elderly people.

Report: Policy Stunting Growth of German Pharma Industry

April 15, 2015 10:34 am | by Andy Szal, Digital Reporter | News | Comments

A 2011 law overhauling the German pharmaceutical industry will be the biggest impediment to growth in the sector over the next several years, according to a new report.

PBOA Hosts Workshop

April 15, 2015 10:29 am | by Pharma & Biopharma Outsourcing Association | News | Comments

On March 30, the Pharma & Biopharma Outsourcing Association (PBOA) held its first Regulatory/Legislative Workshop.

Global Duchenne Muscular Dystrophy Treatment Market to See Spectacular Growth by 2019

April 14, 2015 2:38 pm | by GlobalData | News | Comments

The global treatment market for Duchenne Muscular Dystrophy (DMD) will expand in value at a staggering Compound Annual Growth Rate (CAGR) of 160.5%, from approximately $8.2 million in 2014 to $990 million by 2019, says research and consulting firm GlobalData.

Recipharm Equity Investment in Synthonics

April 14, 2015 11:43 am | by Recipharm | News | Comments

$2.0 million of preferred stock will be purchased upon Synthonics’ achievement of certain milestones, which could be expected during 2016.

Rentschler Biotechnologie Expands Biopharm Capabilities

April 14, 2015 11:28 am | by GE Healthcare | News | Comments

GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH announced the expansion of Rentschler’s biopharmaceutical manufacturing capabilities.

Ventana and Astellas Work on Targeted Cancer Treatments

April 14, 2015 11:09 am | by Ventana Medical Systems, Inc. | News | Comments

Ventana, a member of the Roche Group, announced it has entered into a master collaboration agreement with Astellas Pharma Inc.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.